This article reports the results of a clinical study of 41 patients with ma
ndibular osteoradionecrosis. Patients were divided into research arms to re
ceive either post resection (of the radiation-damaged bone) hyperbaric oxyg
en (HBO) treatment, repeated debridement and clindamycin, or debridement an
d clindamycin without HBO. Assignment to HBO and no HBO groups was based on
the availability of HBO at participating institutions. It is unclear from
the article what means were used to standardize debridement protocols and s
uccess criteria.
The authors found that patients receiving HBO not only did not receive a be
nefit, but also had poorer outcomes than did those not receiving HBO. The a
uthors concede that the study numbers are relatively low but conclude that
HBO should not be recommended for treatment of severe osteoradionecrosis af
ter an initial resectioning of the involved mandible. They do appear to rec
ommend following the protocol of preoperative and postoperative HBO for pre
vention and preresection of osteoradionecrosis.